News

The chemical company BASF has attained a global, non-exclusive licensing agreement with the Broad Institute of MIT and Harvard for the use of CRISPR-Cpf1 genome editing technology to improve products in agricultural and industrial microbiology applications.

“When the gut barrier is healthy, probiotics are beneficial. When it is compromised, however, they can cause more harm than good. Essentially, ‘good fences make good neighbors.’ ”

The use of minute doses of magic mushrooms and truffles containing psychedelic substances could induce a state of unconstrained thought that may produce more new, creative ideas, say study.

A series of experiments have been designed to develop new medications that could potentially fight off the resistant and sensitive types of influenza A.

Studies using antibiotic-treated mice reveal mechanisms that increase susceptibility to Clostridioides difficile infection (CDI), but risk factors associated with CDI in humans extend beyond antibiotic use.

Single direct-to-tumor drug-delivery device, smaller than a grain of rice, offers hope for treating triple-negative breast cancer.

Cryo-electron microscopy imaging reveals an intricate arrangement of antibodies locked into a spiral structure with a parasite protein. The insights are key for improving malaria vaccine candidates.

Immunotherapy on its own is better than aggressive chemotherapy as a first-line treatment for advanced head and neck cancer, according to surprising new data from a major phase III clinical trial.

A new vaccine strategy could offer protection to millions of chickens threatened by a serious respiratory disease.

This research demonstrates a signaling pathway that can be activated by different methods and could represent a new approach to cochlear regeneration and, ultimately, restoration of hearing.